
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
For detailed information, please contact Dr. Weinacker's office.
All Other Third Party
Blue Shield of California
Conifer Health Solutions
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
Santa Clara Family Health Plan
State of California
UnitedHealthcare
View All Insurances
Latent class alysis identifies distinct phenotypes of primary graft dysfunction after lung
Chest, 2013
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013
Still a man's world, but why?
Critical care (London, England), 2013
Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation
PLOS ONE, 2012
Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction
JOURL OF HEART AND LUNG TRANSPLANTATION, 2012
High prevalence of corrected QT interval prolongation
CRITICAL CARE MEDICINE, 2012
Obesity and Primary Graft Dysfunction after Lung Transplantation The Lung Transplant Outcomes Group
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011
Elevated Plasma Long Pentraxin-3 Levels
AMERICAN JOURL OF TRANSPLANTATION, 2011
Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels
CHEST, 2011
Elevated Pulmory Artery Pressure Is a Risk Factor
CHEST, 2011
Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High
AMERICAN JOURL OF TRANSPLANTATION, 2011
The Slow Code Should Be a No Code
AMERICAN JOURL OF BIOETHICS, 2011
Construct validity of the definition of primary graft dysfunction after lung transplantation
JOURL OF HEART AND LUNG TRANSPLANTATION, 2010
Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009
Soluble P-Selectin and the Risk of Primary Graft Dysfunction After Lung Transplantation
CHEST, 2009
Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation
AMERICAN JOURL OF TRANSPLANTATION, 2009
Randomized clinical trial of activated protein C for the treatment of acute lung injury
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008
Plasma intercellular adhesion molecule
AMERICAN JOURL OF TRANSPLANTATION, 2007
Magement strategies for patients with pulmory hypertension in the intensive care unit
CRITICAL CARE MEDICINE, 2007
Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction
AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007
Smoking in movies
CHEST, 2006
High dose cyclophosphamide efficacy in a patient with refractory anti
Muscle & Nerve, 2006
Smoking in contemporary American cinema
CHEST, 2005
The value of preoperative pulmory rehabilitation.
Thoracic surgery clinics, 2005
Lung transplantation: A decade of experience
J Heart Lung Transplant, 2005
Intensive care unit support of hematopoietic stem cell transplant recipients
CRITICAL CARE MEDICINE, 2003
Variability in antibiotic prescribing patterns
CHEST, 2003
Blood cultures in the critical care unit - Improving utilization and yield
CHEST, 2002
Ethical issues in the long term magement of progressive degenerative neuromuscular diseases
SEMIRS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2002
Nodular invasive tracheobronchitis due to Aspergillus
LUPUS, 2002
A cystic upper lobe lesion in a healthy nonsmoking man - Angiosarcoma of the left upper lobe
CHEST, 2001
Diagnostic yield of screening colonoscopies in lung transplant candidates
Singer, L. G., Weicker, A. B., Levin, L., Doyle, R. L., Theodore, J., 2001
Acute respiratory distress syndrome: Physiology and new magement strategies
ANNUAL REVIEW OF MEDICINE, 2001
A brave new world: Remote intensive care unit care for the 21st century
CRITICAL CARE MEDICINE, 2000
Withdrawing life support from the critically ill
CHEST, 2000
The patient's response to medical futility
ARCHIVES OF INTERL MEDICINE, 2000
Inhalatiol anthrax - Epidemiology, diagnosis, and magement
CHEST, 1999
Quality of life and lung volume reduction surgery.
American jourl of critical care, 1999
beta-adrenergic-blocking agents in bronchospastic diseases: A therapeutic dilemma
PHARMACOTHERAPY, 1999
Systematic reviews and evidence-based critical care medicine: A step in the right direction
AMERICAN JOURL OF MEDICINE, 1998
The treatment of malignt mesothelioma with a gene modified cancer cell line: A phase I study
HUMAN GENE THERAPY, 1998
Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignt mesothelioma
AMERICAN JOURL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998
Gene therapy for malignt mesothelioma
jourl of the Louisia State Medical Society, 1998
DISTRIBUTION OF INTEGRINS ALPHA-V-BETA-6 AND ALPHA-9-BETA-1 AND THEIR KNOWN LIGANDS
AMERICAN JOURL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995
ROLE OF THE INTEGRIN ALPHA-V
JOURL OF BIOLOGICAL CHEMISTRY, 1994
IDIOPATHIC GIANT BULLOUS EMPHYSEMA (VANISHING LUNG SYNDROME) - IMAGING FINDINGS IN 9 PATIENTS
AMERICAN JOURL OF ROENTGENOLOGY, 1994
EFFECTS OF BETA-SUBUNIT CYTOPLASMIC DOMAIN DELETIONS ON THE RECRUITMENT OF THE INTEGRIN ALPHA
CELL ADHESION AND COMMUNICATION, 1994
UPPER AND MIDDLE LOBE BRONCHOALVEOLAR LAVAGE TO DIAGNOSE PNEUMOCYSTIS-CARINII PNEUMONIA
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993